**Question:** One of the following drugs can slow the loss of alveolar bone in periodontitis:

A. Amoxicillin
B. Metformin
C. Vitamin D
D. Calcium supplements

**Correct Answer: C. Vitamin D**

**Core Concept:** Periodontitis is an inflammatory disease affecting the supporting tissues of the teeth, leading to progressive loss of alveolar bone. Vitamin D plays a crucial role in maintaining bone health and mineralization, as it regulates calcium and phosphorus levels in the blood.

**Why the Correct Answer is Right:** Vitamin D is essential for calcium and phosphorus absorption from the gastrointestinal tract. It achieves this by binding to its receptor, vitamin D receptor (VDR), which then interacts with the vitamin D response element (VDRE) in the gene promoter region of target cells. This binding leads to transcription of genes involved in calcium and phosphate homeostasis, ultimately promoting bone mineralization.

In the context of periodontitis, vitamin D helps in preserving alveolar bone by maintaining proper calcium and phosphorus levels, which are essential for bone mineralization.

**Why Each Wrong Option is Incorrect:**

A. Amoxicillin: Amoxicillin is a penicillin antibiotic used to treat bacterial infections, not related to bone health or periodontitis management.

B. Metformin: Metformin is an antidiabetic drug, primarily targeting glucose control, not bone health or periodontitis management.

D. Calcium supplements: While calcium supplements can increase calcium levels, they do not address the underlying inflammation and bone loss in periodontitis, making vitamin D a more suitable choice.

**Clinical Pearl:** Vitamin D deficiency has been linked to increased risk of periodontitis progression. Ensuring adequate vitamin D levels can protect bone health, particularly in patients with periodontitis. Maintaining optimal vitamin D levels, along with addressing underlying infections and implementing proper oral hygiene measures, is crucial for managing periodontitis and preserving alveolar bone.